本页面由Tiger Trade Technology Pte. Ltd.提供服务

Regentis Biomaterials Ltd.

1.63
+0.03001.87%
盘前:1.640.0056+0.34%04:33 EDT
成交量:3.61万
成交额:5.87万
市值:1,146.95万
市盈率:-0.62
高:1.65
开:1.62
低:1.60
收:1.60
52周最高:15.50
52周最低:1.23
股本:703.65万
流通股本:484.22万
量比:0.51
换手率:0.75%
股息:- -
股息率:- -
每股收益(TTM):-2.6440
每股收益(LYR):-24.1600
净资产收益率:--
总资产收益率:-113.59%
市净率:1.49
市盈率(LYR):-0.07

数据加载中...

2026/08/13

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/08

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/06/09

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/05/29

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/01

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/02/27

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2026/02/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/10/24

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/10/24

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/10/06

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/09/30

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/18

SEC问询函

Form CORRESP - Correspondence
2025/09/18

SEC问询函

Form CORRESP - Correspondence
2025/09/16

SEC问询函

Form CORRESP - Correspondence
2025/09/16

SEC问询函

Form CORRESP - Correspondence
2025/09/11

SEC问询函

Form CORRESP - Correspondence
2025/09/09

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/09

SEC问询函

Form CORRESP - Correspondence
2025/09/09

SEC问询函

Form CORRESP - Correspondence